Glenmark gets FDA nod for Theophylline Extended-Release Tablets generic

pallavi123- June 4, 2021 0

Glenmark Pharmaceuticals has secured final approval from the US Food and Drug Administration (FDA) for Theophylline Extended-Release Tablets, 300 mg, and 450 mg. The Indian ... Read More

LUMAKRAS FDA approval : Amgen bags approval in KRAS G12C-mutated NSCLC

pallavi123- May 29, 2021 0

LUMAKRAS FDA approval : Amgen has bagged accelerated approval from the US Food and Drug Administration (FDA) for LUMAKRAS (sotorasib) for the treatment of a ... Read More

Zydus Cadila gets FDA approval for Fluphenazine Hydrochloride Tablets

pallavi123- May 29, 2021 0

Cadila Healthcare (also known as Zydus Cadila) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Fluphenazine ... Read More

Alembic Pharmaceuticals gets FDA final approval for Doxepin Hydrochloride Capsules

pallavi123- April 24, 2021 0

Alembic Pharmaceuticals announces USFDA Final Approval for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg and 100 mg. Alembic Pharmaceuticals has ... Read More

BMS, bluebird bio bag Abecma FDA approval for multiple myeloma in adults

pallavi123- March 28, 2021 0

Abecma FDA approval : Bristol Myers Squibb (BMS) and bluebird bio have secured approval from the US Food and Drug Administration (FDA) for Abecma (idecabtagene ... Read More

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

pallavi123- February 28, 2021 0

Johnson & Johnson (J&J) said that the US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for Ad26.COV2.S, a single-dose COVID-19 vaccine ... Read More

FDA grants emergency use authorization to Janssen COVID-19 vaccine

pharmanewsdaily- February 28, 2021 0

The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the Janssen COVID-19 Vaccine, Ad26.COV2.S, developed by Johnson & Johnson's ... Read More

FDA approves G1 Therapeutics’ Cosela for reducing chemotherapy-induced bone marrow suppression

pharmanewsdaily- February 15, 2021 0

G1 Therapeutics has achieved a significant milestone with the recent U.S. Food and Drug Administration (FDA) approval of Cosela (trilaciclib), a pioneering treatment designed to ... Read More

FDA approves Opdivo and Cabometyx combo for advanced kidney cancer treatment

pharmanewsdaily- January 26, 2021 0

The U.S. Food and Drug Administration (FDA) has officially approved the combination of Bristol Myers Squibb's Opdivo (nivolumab) and Exelixis' Cabometyx (cabozantinib) for the first-line ... Read More

ViiV Healthcare’s Cabenuva secures FDA approval for HIV treatment

pharmanewsdaily- January 24, 2021 0

ViiV Healthcare has received FDA approval for Cabenuva, a long-acting treatment regimen for HIV-1 infection in adult patients. This new therapy is poised to transform ... Read More